Israel-based AION Labs, an AI-enabled drug discovery partnership between global pharma and tech companies, announced the launch of its second startup, DenovAI.
DenovAI will develop an AI-enabled computational biophysics platform that can discover potential antibodies directed toward specific epitopes (the part of an antigen molecule recognized by the immune system to which an antibody attaches...
Copenhagen-based digital health company Dawn Health announced a strategic partnership with pharma giant Novartis to develop a chronic condition management platform.
Under the collaboration, Dawn and Novartis will build remote monitoring and management tools for chronic conditions where they see an unmet need and concerns around disease progression, like multiple sclerosis, hypertension,...
Mark Cuban Cost Plus Drug Company (MCCPDC) is partnering with diabetes and chronic disease management company Diathrive Health to provide lower-cost prescription medication and diabetes testing supplies to Diathrive's members.
Diathrive Health offers individuals and employers personalized coaching via live messaging and video chat, as well as care plans, articles and videos to help manage...
The Digital Medicine Society (DiMe) and a suite of digital health and pharma players partnered to launch a toolkit aimed at improving diversity, equity and inclusion in clinical trials.
The resources include a guide to each step of a digital clinical trial, shared definitions of terms like "diversity" and "equity," a list of different digital tools that could be used and the potential benefits...
Online pharmacy platform SwipeRx has received $10 million in additional Series B funding from marquee investors, including Sanofi’s Global Health Unit and Cercano Management. The round was also joined by its existing investors, SIG, Johnson & Johnson, and Patamar Capital.
The company, which has a network of over 250,00 pharmacy professionals and 50,000 pharmacies, initially raised $27 million...
Mark Cuban Cost Plus Drug Company (MCCPDC) is partnering with cancer care support company OncoPower to offer prescription drugs at a decreased cost via a platform dubbed Medication Savings Suite.
The suite will be integrated within OncoPower's Pill Reminder Tool, which will alert patients of cheaper generic medication options available through MCCPDC when patients log a new medication into the...
Tech-enabled clinical trial platform Paradigm announced its launch alongside a $203 million Series A funding round co-led by ARCH Venture Partners and General Catalyst.
F-Prime Capital, LUX Capital, GV, Magnetic Ventures and Mubadala Capital also participated in the round. American Cancer Society's BrightEdge fund was a strategic investor.
The company also announced its acquisition of Deep Lens...
Two Japanese companies, health tech firm Four H and Aculys Pharma, a biopharmaceutical company focused on treating mental health disorders, are collaborating to further understand and help people with sleeping disorders.
Their goal is to have an objective understanding of sleeping disorders, particularly narcolepsy and excessive daytime sleepiness associated with obstructive sleep apnea (OSA)....
Kroger Health, the healthcare division of the large grocery chain, announced Tuesday it had launched a clinical trial site network.
The company said it will work with trial sponsors, contract research organizations and health systems to conduct clinical trials out of select Kroger pharmacies and clinics. It will also use virtual care and digital health tools to ensure patients stay enrolled in...
In its latest dive into healthcare, Amazon is launching a generic medication subscription service through its online pharmacy.
RxPass, which will be available to Prime members, will deliver generic drugs for common conditions like high blood pressure, anxiety and acid reflux. The tech and retail giant said the service will cost a flat fee of $5 per month.
The program won't accept insurance, and...